ID: ALA3249165

Max Phase: Preclinical

Molecular Formula: C22H28N2O2

Molecular Weight: 352.48

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CN(C)CCN1CCC(O)(c2ccccc2)C(C(=O)c2ccccc2)C1

Standard InChI:  InChI=1S/C22H28N2O2/c1-23(2)15-16-24-14-13-22(26,19-11-7-4-8-12-19)20(17-24)21(25)18-9-5-3-6-10-18/h3-12,20,26H,13-17H2,1-2H3

Standard InChI Key:  OBPVGZCQIXQUBB-UHFFFAOYSA-N

Associated Targets(non-human)

Heart 171 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Canis familiaris 36305 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 352.48Molecular Weight (Monoisotopic): 352.2151AlogP: 2.64#Rotatable Bonds: 6
Polar Surface Area: 43.78Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.60CX Basic pKa: 8.22CX LogP: 2.54CX LogD: 1.66
Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.81Np Likeness Score: -0.31

References

1. Ellefson CR, Woo CM, Cusic JW..  (1978)  Synthesis and antiarrhythmic activity of 2-dialkylaminoalkyl-9-phenyl-1H-indeno[2,1-c]pyridine derivatives.,  21  (4): [PMID:650662] [10.1021/jm00202a005]

Source